Skip to content

Nitrous Oxide Induction Induces Amnesia in Pediatric Patients

Dose Response Effect of Nitrous Oxide on Amnesia in Healthy Children

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02050152
Enrollment
90
Registered
2014-01-30
Start date
2013-05-01
Completion date
2013-10-01
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amnesia

Keywords

Amnesia, Memory, Implicit, Explicit, Nitrous Oxide

Brief summary

The investigators are conducting a study to investigate the amnestic effects of 2 different concentrations of nitrous oxide in children before induction of anesthesia in a prospective double-blinded placebo controlled study.

Detailed description

Children of age group 6-12 will be randomly divided in 3 groups, First group will be Placebo , second group will be nitrous oxide end tidal 33% and third group will be nitrous oxide 66%. Each group will be divided into 2 subgroups randomly with either a flavored or unflavored mask for induction. All children will be told a joke before the mask is applied, with the answer provided after the end-tidal nitrous oxide concentration reaches the randomized concentration (0, 33 or 66%) for at least one minute. At that point, the child will randomized to be either shown a picture of one of four animals (predetermined randomly) or a food will be stated aloud. For the animal, the child will be asked to name the animal aloud. The child's response (yes or no to a response and whether the item is correctly named) will be recorded. If the child does not respond, the name of the animal will be stated out loud. For the food, one of four foods will be named aloud and child will be asked to repeat the name. The child's response (named or not) will be recorded. Anesthesia will continue with the designated nitrous oxide concentration combined with 8% Sevoflurane. When the child is ready for discharge from the recovery room and recovered from anesthesia, a nurse or doctor who is blinded to the treatment group assignment will ask the child to recall the joke and answer. The child will then be asked if they were shown any animals and if so, which animal? If the child cannot recall an animal, the child will be asked to name the first animal that comes to mind. The child will then be shown pictures of four animals and asked to identify one. The child will be asked if they heard any foods when they went to sleep? If the child cannot recall hearing any foods recited, the first letter of the food will be shown: B \_ \_ \_ \_ \_ . If the child does not recall any foods, then the child will be given the names of four foods that begin with the letter B and asked to pick one. Finally, the child will be asked about any odors in the mask during anesthesia. If he/she does not recall, then four odors will be read out and the child asked to identify any one. Additionally, the children will be asked whether they recall any odors on the mask as they were anesthetized. The order of items questioned in the recovery period will follow the same order as in the OR.

Interventions

DRUGNitrous Oxide 0%

Behavior: recall at discharge from hospital will be tested for the content of photos and a joke told while breathing a mask

DRUGNitrous oxide 33%

Behavior: recall at discharge from hospital will be tested for the content of photos and a joke told while breathing a mask

DRUGNitrous oxide 66%

Behavior: recall at discharge from hospital will be tested for the content of photos and a joke told while breathing a mask

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

1. Age: 6-12 years old, 2. ASA classification: 1 and 2 3. Elective surgery

Exclusion criteria

1. Uncooperative child needs sedation before induction of anesthesia 2. Developmental delay, ADHD, autism, Tourette's syndrome, schizophrenia, congenital and acquired brain disorder, Down syndrome. 3. Those who request for IV induction 4. Those taking sedative medications, anti-seizure medication 5. Those with malignant hyperthermia, muscular dystrophy; those with uncorrected cardiac defects and those with severe or active lung disease 6. Those with elective admissions to PICU with ongoing sedation and tracheal intubation

Design outcomes

Primary

MeasureTime frameDescription
Explicit MemoryAfter full recovery from anesthesia (generally by 2 hours after termination of anesthesia), but before discharge from hospital all variables will be assessedExplicit memory will be tested during the recovery period (once the child has fully recovered from anesthesia but before discharge from hospital) by a blinded observer who will ask the child whether they smelled za bad odor while they breathed through the mask.

Secondary

MeasureTime frameDescription
Explicit MemoryAfter recovery from anesthesia (in recovery room or before discharge from hospital) within 4 hours of anesthesia completionExplicit memory will be tested for the child recalling the riddle and answer after the study
Explicit Memory if the Child Remembered Being Shown an Animal in a Photo2 hours after anesthesiaThe child will be shown the photo of an animal while they were breathing through the mask and then asked to recall which animal they were shown in the photo during the mask induction
Explicit Memory of the Name of a Food That Begins With the Letter "b"2 hours after anesthesiaThe child will be asked if they recall hearing the name of a good that began with the letter "b" while breathing the mask

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJerrold Lerman, MD, FRCPC

Professor

Baseline characteristics

Characteristic
Age, Continuous8.2 years
STANDARD_DEVIATION 1.8
Region of Enrollment
United States
31 participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
35 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 290 / 31
other
Total, other adverse events
0 / 300 / 290 / 31
serious
Total, serious adverse events
0 / 300 / 290 / 31

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026